India Moves To Shift Drugs Oversight To New Department
This article was originally published in PharmAsia News
Executive Summary
India's government has decided to create a separate department to oversee the pharmaceutical industry, but the process is expected to take several months. The Department of Chemicals and Fertilisers currently has responsibility for the drug sector, but the plan now is to take drug policy away from the department and establish a separate authority that would include the National Pharmaceutical Pricing Authority. The Drug Controller General of India is to remain a part of the Health Ministry instead and is not to become part of the pharmaceuticals department. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.